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http://dxObjectives: This study investigated the time-dependent remodeling and growth potential of porcine small
intestine submucosa as a biomaterial for the reconstruction of pulmonary arteries in a lamb model.
Methods: Left pulmonary arteries were partially replaced with small intestine submucosal biomaterial in 6
lambs. Two animals each were humanely killed at 1, 3, and 6 months. Computed tomographic angiography,
macroscopic examination of the implanted patch, and microscopic analysis of tissue explants were performed.
Results: All animals survived without complications. Patency and arborization of the pulmonary arteries were
detected 6 months after implantation. There was no macroscopic narrowing or aneurysm formation in the patch
area. The luminal appearance of the patch was similar to the intimal layer of the adjacent native pulmonary ar-
tery. Scanning electron microscopy showed that the luminal surface of the patch was covered by confluent cells.
Immunohistochemical examination confirmed endothelialization of the luminal side of the patch in all of the
explanted patches. The presence of smooth muscle cells in the medial layer was confirmed at all time points;
however, expression of elastin, growth of the muscular layer, and complete degradation of patch material
were detectable only after 6 months. The presence of c-Kit–positive cells suggests migration of multipotent cells
into the patch, which may play a role in remodeling the small intestine submucosal biomaterial.
Conclusions: Our data confirmed that remodeling and growth potential of the small intestine submucosal bio-
material are time dependent. Additional experiments are required to investigate the stability of the patch material
over a longer period. (J Thorac Cardiovasc Surg 2012;144:963-9)Supplemental material is available online.E
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SThe reconstruction of defective or hypoplastic pulmonary
artery (PA) is a common surgical procedure performed in
pediatric patients with congenital cardiovascular disease.
Augmentation of the PA is often implemented during the
first year of life and requires synthetic or biologic patch ma-
terials. Although the outcomes of surgically repaired hypo-
plastic PAs have improved,1 frequent reoperations are
unavoidable because commercially available graft mate-
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The Journal of Thoracic and Caaddition to having growth potential, ideal vascular patches
should be readily available, easy to handle, and resistant
to degeneration or infection.2,3 Recently, the application
of extracellular matrix (ECM) has been gaining more
attention as a possible biomaterial for cardiovascular
repair.4 ECM biomaterials are mammalian decellularized
tissues with preserved ECM components that may be har-
vested from various tissue sources.5,6 Small intestinal
submucosa (SIS) is an ECM biomaterial that is widely
used in clinical and animal studies.7-13 The biologic and
mechanical characteristics of SIS biomaterials depend on
the source of tissue, the age of the animal, and the
preparation process.14,15 It has been shown that the
alteration of biologic and mechanical properties of the
implanted SIS patch biomaterials depends on the new
in vivo microenvironment.16,17 The structural integrity of
SIS biomaterial is critical to the stability of implantation;
however, activation of the host healing process is closely
dependent on the degradation of ECM SIS.5 A balance be-
tween the rate of ECM degradation and host remodeling is
therefore critical for a successful surgical outcome.
Application of SIS biomaterial for the reconstruction of
congenital vascular defects has shown promising results
with regard to the patency of repaired vessels in pediatric
patients8; however, remodeling and growth potential of
the SIS patch remain the major concern. The goal of this
study was to investigate time-dependent remodeling andrdiovascular Surgery c Volume 144, Number 4 963
Abbreviations and Acronyms
ECM ¼ extracellular matrix
PA ¼ pulmonary artery
SIS ¼ small intestinal submucosa
SMA ¼ smooth muscle actin
vWF ¼ von Willebrand factor




Sgrowth potential of porcine SIS biomaterial for the recon-
struction of PA in a lamb surgical model.
MATERIALS AND METHODS
Animals
Six Suffolk lambs, weighing approximately 10 to 20 kg, were used for
this study (provided by Center for Laboratory Animal Science, Davis,
Calif). All animals received humane care in compliance with the Guide for
the Care and Use of Laboratory Animals (www.nap.edu/catalog/5140.html).
Surgical Procedures
Animals fasted for 24 to 48 hours before surgery. All surgical proce-
dures were performed with aseptic technique. Anesthesia was induced ei-
ther with intravenously administered ketamine hydrochloride (INN
ketamine) and diazepam or with isoflurane by mask. After intubation,
the animals were mechanically ventilated and anesthesia was maintained
with inhalation of 1% to 2.5% isoflurane. The animals were placed in
the right lateral decubitus position, their wool was clipped, and a sterile
preparation of the area was accomplished. A left lateral thoracotomy was
performed. The pericardium was opened anteriorly to the phrenic nerve,
and the left PA was isolated. Heparin was administered intravenously at
300 U/kg. Vascular clamps were used to clamp the left main PA temporar-
ily. Partial resection of the vessel was made, and the SIS patch (53 10mm)
was placed with 6-0 polypropylene running sutures. After de-airing,
clamps were removed. Bupivacaine hydrochloride (INN bupivacaine;
0.25%-0.5%) was injected into the area around thoracotomy for postoper-
ative analgesia before closure of the chest. The chest was closed in the stan-
dard fashion, with placement of a temporary chest tube that was removed
a few minutes later, just before the animal extubation on the operating ta-
ble. Aspirin (325 mg) was given orally once a day for 7 days postopera-
tively to prevent acute thrombosis on the surface of implanted materials.
After recovery, the animals were housed in free-walking pens until elec-
tive killing. The patch materials were harvested at 1-, 3-, and 6-month in-
tervals after implantation. Two lambs from each group were made to fast
for 24 hours. Each animal was then intubated and anesthetized with isoflur-
ane andmechanically ventilated. The chest was reopened, andmacroscopic
investigation was done to assess the size and shape of the vessels. Left PA
pressures proximal and distal to the patch were recorded by direct puncture.
Finally, the animals were humanely killed with intravenous pentobarbital
or intravenous saturated potassium chloride, and the vessels were harvested
for histological study.
Computed Tomographic Angiography
Patency of the graft was assessed in all animals by macroscopic exam-
ination and direct pressure measurement at the moment of the explants.
Furthermore, 2 animals underwent computed tomographic angiographic
scan of the lungs at 6 months after implantation to assess patency and ar-
borization pattern of the branch PAs before death.
Scanning Electron Microscopy
Small longitudinal sections of the explanted grafts were fixed for scan-
ning electron microscopy (model S-3400N VP-SEM; Hitachi, Tokyo,964 The Journal of Thoracic and Cardiovascular SurgJapan). Scanning electron microscopy was performed to show the appear-
ance of the luminal surface of the patched area.
Histologic and Immunohistochemical Studies
The explanted SIS vascular patch, along with a piece of native PA, was
dissected and fixed in 10% buffered formalin (Fisher Scientific, Fair Lawn,
NJ). The tissues were embedded in paraffin and, 5-mm tissue sections were
prepared for Russell-Movat pentachrome staining (American Master Tech
Scientific, Inc, Lodi, Calif). Immunohistologic analyses were performed
for the endothelial cell marker vonWillebrand factor (vWF; Dako Cytoma-
tion, Glostrup, Denmark), smooth muscle actin (SMA; Dako Cytomation),
elastin (Abcam Inc, Cambridge, Mass), and the stem cell marker CD117
(c-Kit; Dako Cytomation). The thickness of the tissue explants was mea-
sured with image analysis software (LAS AF image analysis; Leica Micro-
systems Inc, Buffalo Grove, Ill).
RESULTS
Postoperative Course and Gross Examination
All 6 lambs survived surgery and the postoperative period
without complications or signs of infection. The mean ani-
mal weight increased from 17.5 kg at the first operation to
23.9, 51.7, and 53.4 kg at 1, 3, and 6 months, respectively.
At the time of explantation of patch material, the areas
around the left PA and patch material presented a normal
appearance. Formation of adhesion fibers around the suture
lines was found 1 month after the first operation (Figure 1,
A), and was reduced 6 months after implantation. The
patched area did not show any narrowing or aneurysm for-
mation, nor was there a pressure gradient across the patch.
The luminal surface of the explanted patch was shiny and
smooth, similar to the luminal surface of adjacent native
left PA (Figure 1, B). This was observed at all time points.
Therewas no thrombus formation on the endothelial surface
of any explanted graft.
In Vivo Imaging Analysis
The computed tomographic angiographic scan with
3-dimensional reconstruction showed patency of the left
PA without any sign of stenosis or aneurysm formation.
The left and right PA sizes were normal and comparable
with one another, as was the distal arborization after each
PA branch (Figure 2).
Scanning Electron Microscopy
The scanning electron microscopy revealed the endolu-
minal aspect of the patch to be covered by confluent cells
with the morphologic characteristics of endothelial cells
from the first month after implantation (Figure 3).
Histologic and Immunohistochemical Studies
Our histologic analysis showed recellularization of
grafted patch after 1 month (Figure 4, A); however, forma-
tion of ECM was limited to proteoglycan (Figure 4, B), in
contrast to elastin fibers in native artery (Figure 4, C). A dif-
fuse infiltration of inflammatory cells into the adventitia in-
creased the thickness of the grafted patch (Figure 4, D)ery c October 2012
FIGURE 1. A, In situ macroscopic appearance of patched area 1 month after implantation. Arrows show patched area externally. There were no visible
adherences around the patch area. The external caliber of the left pulmonary artery (LPA) was free from stricture formation and distortions. B, Macroscopic
view of the luminal surface of the explanted patch 1month after implantation shows the patched area in the middle of the specimen (the left pulmonary artery
was opened longitudinally). The intimal layer was found covering the luminal surface of the constructed left pulmonary artery, including the patched area.
MPA, Main pulmonary artery; SIS, small intestine submucosal patch.
Boni et al Evolving Technology/Basic Sciencerelative to the adventitia of native PA (Figure 4, E). An in-
crease in the size of the arterial lumen was observed 3
months after implantation (Figure 4, F). The activation of
the repair process within the patch was confirmed by the de-
tection of newly formed blood vessels in the medial part of
patch (Figure 4, G) and also by the reduction of inflamma-
tory response in the adventitia (Figure 4, I). In addition, al-
teration of the ECM was observed by the production of
collagen in the subintimal and medial parts of grafted patch.
Six months after implantation, the morphology of the SIS
patch mimicked the structure of native arterial wall
(Figure 4, K). The formation of elastin fibers provided evi-
dence for arterialization of SIS patch (Figure 4, L).FIGURE 2. Computed tomographic angiographic scan with
3-dimensional reconstruction 6 months after patch implantation. The left
pulmonary artery (LPA) was patent, and there were no signs of stenosis
or aneurysm formation. The left pulmonary artery and right pulmonary ar-
tery (RPA) sizes were normal and comparable with each other, as was the
distal arborization after each pulmonary arterial branch. Ao, Aorta; MPA,
main pulmonary artery.
The Journal of Thoracic and CaFurthermore, the reduction of inflammatory response and
a consequent reduction of patch thickness were observed
(Figure 4, N).
To characterize the cellular structure of implanted patch,
immunohistologic analysis was performed. Endothelializa-
tion of the luminal side of the SIS patch was confirmed by
the expression of endothelial cell marker vWF in the cells
covering the lumen 1, 3, and 6 months after implantation
(Figure 5, A, E, and I, respectively). The presence of smooth
muscle cells in the medial layer of the patch was confirmed
by the expression of SMA after 1 month (Figure 5, B), 3
months (Figure 5, F), and 6 months (Figure 5, J). The ex-
pression of elastin fibers required a longer period, however,
and was detectable only in the 6-month vascular patch
(Figure 5,K). The thickness of the tunicamedia in the native
left PA was 2400 mm, and the muscle bundle was around
1200 mm (almost half the arterial wall thickness). TheFIGURE 3. Scanning electron microscopy of the luminal surface of the
small intestine submucosal patch 1 month after implantation. The patch
area was covered with confluent cells with the morphologic characteristics
of endothelial cells. Original magnification 31600.





FIGURE 4. Russell-Movat pentachrome staining of small intestine submucosal (SIS) patch explants. The cross sections of small intestine submucosal
patch tissue explants after 1 month (A) shows cellularization of intima and media (arrows; B). Formation of extracellular matrix is confirmed by production
of collagen (yellow) in subintimal layer and proteoglycans (blue) in the tunica media; however, elastin fibers (black) are only detected in the wall of native
pulmonary artery (C), not in the small intestine submucosal patch. Comparison of tunica adventitia in the small intestine submucosal explants (D) with native
pulmonary artery (E) shows migration of inflammatory cells into the patch, thus increasing the thickness of patch. The cross section of small intestine sub-
mucosal patch tissue explants after 3 months shows increasing the size of pulmonary arterial lumen (F) and formation of blood vessels in the tunica media
(arrows; G). Partial replacement of proteoglycans by collagen is evidence that matrix production in the small intestine submucosal patch tunica media is
dynamic. Distribution of proteoglycans in small intestine submucosal patch follows a pattern similar to that in native pulmonary artery (H). No elastin fiber is
observed in the small intestine submucosal patch after 3 months. Although the number of inflammatory cells in the tunica adventitia of the 3-month-old small
intestine submucosal patch (I) is higher than that in the native pulmonary artery (J), it is dramatically decreased relative to a 1-month sample (D). The cross
section of small intestine submucosal patch tissue explants after 6 months shows reduction of patch thickness (K) and formation of elastin fiber in the patch
(L) with a pattern similar to that in native pulmonary artery (M). The similarity in the distribution of cells and extracellular matrix between small intestine
submucosal patch tunica adventitia (N) and native pulmonary artery (O) indicates the reduction of inflammatory response after 6 months. Original magni-
fications 316 (A, F, and K) and 3400 (B-E, G-J, and L-O).




Sthickness of newly formed muscle layer in the patch was
350 mm, and it was more than a fifth of the 1750-mm thick-
ness of the whole patch.
The existence of the stem cell marker CD117 within the
grafted patch after 1, 3, and 6 months (Figure 5, D, H, and
L, respectively) suggested a source of multipotent cells
that can differentiate into the required vascular cells for re-
population of the SIS patch. Although we could not show966 The Journal of Thoracic and Cardiovascular Surgthe origin of CD117þ cells, the age-dependent increase in
the number of CD117þ cells suggested that these cells
may contribute to the growth and remodeling of the SIS
patch.
Vascularization of the SIS patch 1 and 3 months after im-
plantation (Figure E1, A and B, respectively) provides addi-
tional evidence for the activation of the proliferative phase
of the remodeling process. Regression of newly formedery c October 2012
FIGURE 5. Immunohistologic analysis of porcine small intestine submucosal patch explants. Formation of tunica intima was confirmed by expression of
endothelial cell marker von Willebrand factor (vWF) in the cells covering the luminal side of grafted patch 1 month, 3 months, and 6 months after implan-
tation (A, E, and I, respectively). Expression of smooth muscle actin (SMA) was observed in the medial layer of small intestine submucosal patch after 1
month (B), 3 months (F), and 6 months (J); however, the expression of elastin was observed in the medial layer of only 6-month small intestine submucosal
patch (K), not in the 1-month (C) and 3-month (G) samples. The expression of stem cell marker CD117 (c-Kit) was identified in the small intestine sub-
mucosal patch 1 month (D), 3 months (H), and 6 months (L) after implantation; however, the number and distribution of CD117þ cells increased with
time, indicating the remodeling potential of small intestine submucosal patch. Original magnification 31000 (A-L).




Stissue suggests maturation of the remodeling process after 6
months (Figure 1, C), at which time the perfused vessels
were mostly localized in the adventitia to supply the new
arterial wall.
DISCUSSION
In this study, we investigated time-dependent recellulari-
zation and remodeling of porcine SIS grafted into the left
PA in a lamb model. The vascular structure of the SIS graft
was determined by histologic and immunohistologic stain-
ing at 1-, 3-, and 6-month intervals after implantation. For-
mation of tunica intima was confirmed by expression of
vWF on the luminal side of the SIS patch in all 3 groups.
Expression of SMA in the medial layer of the SIS patch in-
dicated the formation of tunica media; however, the forma-
tion of elastic fibers was evident later and was not detectable
until 6 months after implantation. The wound healing pro-
cess was initiated by the recruitment of inflammatory cells
and was continued by the vascularization of SIS patch 1
month and 3 months after implantation, respectively. Reso-
lution of inflammation and regression of newly formed
blood vessels within the patch were evident 6 months after
implantation. The patency of the reconstructed PA wasThe Journal of Thoracic and Caconfirmed by direct measurement of arterial pressure, com-
puted tomographic angiographic scan, and macroscopic ex-
amination at explantation. The increasing thickness of the
implanted SIS patches was measured microscopically.
Identification of CD117þ cells within the patch suggests
the possible contribution of hematopoietic stem cells to
the remodeling of the SIS patch.
The application of autograft SIS biomaterial for recon-
struction of superior and inferior venae cavae was intro-
duced by Matsumoto and colleagues18 in 1966. Since
then, many efforts have been made to improve the biologic
and mechanical properties of SIS biomaterials. The ECM
components provide a suitable matrix for the migration of
inflammatory cells, circulating bone marrow–derived
cells, and cells from the adjacent native tissue into the
ECM matrix.19,20 The differentiation of the migrated
cells into endothelial and smooth muscle cells is critical
to recellularization of the vascular patch biomaterial.
Endothelialization of the SIS vascular patch was
detectable 1, 3, and 6 months after implantation. The
presence of smooth muscle cells was confirmed by
expression of SMA in the cells located in the medial layer
of the patch. Production of elastic fibers has beenrdiovascular Surgery c Volume 144, Number 4 967




Sidentified as characteristic of arterial smooth muscle cells.21
Production of elastic fibers was time dependent, however,
and it was only detectable 6 months after implantation of
the SIS patch. Elastin plays an important role in the vascular
structure and function in response to mechanical force. The
critical role of elastic fibers in the stability of the arterial
wall has been studied in Marfan syndrome, in which the
degradation of elastic fibers in the large arteries results in
aneurysms.22 Although we did not find aneurysms in the
implanted vascular patches, the slow development of elastic
fibers in the SIS vascular patch and subsequent potential
formation of aneurysms remains a possible concern during
a longer period, as reported by other investigators.23
Activation of inflammatory and wound healing processes
during the remodeling of different kinds of biomaterials has
been reported by other investigators.24,25 It has been shown
that macrophages and lymphocytes play pivotal roles in the
initiation of the matrix remodeling.19 In this study, infiltra-
tion of mononuclear cells was detectable in all the explanted
SIS patches; however, the number of infiltrated cells de-
creased massively 6 months after implantation. Activation
of angiogenesis and deposition of collagen characterized
the proliferative phase of the SIS patch remodeling 3
months after implantation. The regression of newly formed
vessels in the medial layer and the localization of small
vessels in the adventitial layer indicated formation of
vasa vasorum externa in the patch 6 months after
implantation.
The rate of in vivo degradation of SIS biomaterial is crit-
ical for the initiation of the healing process5; however, rapid
absorption of the ECM biomaterial decreases the stability of
the implanted patch and may cause rupture of the con-
structed vessel. The studies with carbon 14–labeled SIS
showed degradation of 60% of the patch material during
the first month and complete absorption of the patch mate-
rial 3 months after repair of the urinary bladder in canine
model.26 In our study, the patch material could be detected
even 3 months after implantation. We speculate that the rate
of patch degradation may depend on the type of recipient
tissue and species.
The growing capacity of SIS biomaterial has been studied
by Robotin-Johnson and coworkers.10 They used autolo-
gous SIS patches for reconstruction of piglet superior venae
cavae. They reported increases in the circumference and
length of implanted patches 3 months after implantation.10
In our study, microscopic measurements were used to eval-
uate the thickness of explanted patch material. Alteration of
the patch thickness was correlated with the phase of patch
remodeling. The thickness of the patch increased during
the inflammatory and proliferative phases and then de-
creased 6 months after implantation. Despite the reduction
in the patch thickness, the thickness of the tunica media in-
creased 6 months after implantation. This suggests that de-
velopment and organization of the muscular bundles might968 The Journal of Thoracic and Cardiovascular Surgrequire a longer period than 6 months to reach the same
thickness as native PA.
Our results showed patency, remodeling, and growth po-
tential of the porcine SIS biomaterial for reconstruction of
PAs in the lamb. More experiments with a greater number
of animals from different species need to be performed to
confirm the significance of these results. Long-term follow
up is required to answer questions regarding stability and
complete remodeling of vascular patches.
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Dr Frank A. Pigula (Boston, Mass). Dr Boni, thank you for
a good presentation and a good manuscript, and congratulations
to your team with this model. These are all difficult models to
perform.
I would note that this material, this SIS, has been used for vas-
cular reconstructions previously. And in fact, this particular prep-
aration has been approved by the Food and Drug Administration
for 3 applications: for pericardial replacement, for intracardiac
patching, and, more recently, in fact late last year, for carotid artery
patching as well.
With that being said, this is among the more careful studies that
I have come across in the literature. You have shown to my satis-
faction that there is a process of change in this SIS graft after im-
plantation and that it appears to transform into PA-like tissue with
time. I do, however, have a couple questions.
One is that you suggested that there was growth potential in the
tissue. Now, did you measure the patch that you put in or measure
the patch that you took out? And how can you be sure that it was
not compensatory growth from the surrounding PA?
Dr Boni. Thank you for the question, Dr Pigula.
We did measure the patch. We found that the patch, in the first
moment, was increasing its thickness, and probably this was due to
the activation of the inflammatory process, which we could seeThe Journal of Thoracic and Camainly in the adventitial layer, where we saw a lot of inflammatory
cells that populated the patch. The reason that we suggest the
growing idea is that when we later assessed the thickness of the
patch, we saw that the medial layer was increasing or growing,
but the full thickness of the patch was decreasing. So the inflam-
mation started to regress after 3 months, and the medial layer
started increasing in size. And apart from this, we could see the ap-
pearance of elastin fibers, which is a marker of an arterial wall.
We cannot say for sure that the patch was growing. We do know
that it was getting repopulated by cells, and we do not know ex-
actly from where they came. We saw CD117+ cells, but we do
not know how it was going, the processing.
Dr Pigula. I guess when I was referring to growth, I was refer-
ring to the surface area growth, rather than the thickness.
Dr Boni.Yes, that’s why I think we probably need longer exper-
iments, because I think the PAwall is an elastic tissue, and we may
need to place bigger patches and follow up for much longer to see
that it is growing in this area.
Dr Pigula.Well, that brings me to my other question regarding
the thickness of the patch and the composition of the patch with
time. You have shown that there was elastin in the tissue at the
end of the 6 months, but it was a fraction of what there is in the
normal PA. So one of the questions for people who may be im-
planting this is what is the mechanical strength of this tissue?
And if there is a transformative process, it is a balance between
degradation of one and regeneration of another and having a me-
chanically safe tissue.
Dr Boni. Yes, of course, this is a very good point. We did not
measure the mechanical force. Other studies did it before and dem-
onstrated a good mechanical force.
And also, measuring the patch, we saw that, for example, rela-
tive to the native PA, the medial layer was more or less a fifth the
full thickness in the patch, whereas in the arterial wall it was half,
with elastin fibers, a few fibers, at 6 months. So that is why I say
that we started to see that the patch was mimicking the arterial
wall, because probably this process was still ongoing. And we
should follow up such animals and do other studies for a longer pe-
riod to assess the complete remodeling, and probably to assess the
mechanical force.
We did not see any aneurysm formation, so in this study we
could not see any problem with the weakness of the patch.
Dr Pigula. Is it being used clinically in your institution?
Dr Boni. Yes, we have been using it clinically. In tiny PAs,
when they are very small, smaller than 3 mm, we have had some
problem, probably because of the initial phase of remodeling,
when the inflammatory process is higher, and we have had some
stenosis of these small structures. So we use it in bigger structures,
and also in PAs but not the tiny ones.rdiovascular Surgery c Volume 144, Number 4 969
FIGURE E1. Activation of angiogenesis in small intestine submucosal patch. Vascularization of small intestine submucosal patch was confirmed by
expression of endothelial marker von Willebrand factor (vWF) in the lumen of newly formed blood vessels in 1-month (A), 3-month (B), and 6-month
(C) explants. The highest density of blood vessels was observed 3 months after patch implantation (B), demonstrating the proliferative phase of patch repair,
whereas regression of blood vessels in the medial layer was identified in 6-month samples (C), indicating maturation and remodeling of grafted patch.
Original magnification 3400 (A-C).
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